Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells

FASEB Journal

Volumn 23, Issue 5, 2009, Pages 1558-1571

  Liberman, Ana C ^a   Druker, Jimena ^a   Refojo, Damian ^a,b   Holsboer, Florian ^b   Arzt, Eduardo ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

GCs; Interleukin 5; p38 mitogen activated protein kinase; T helper 2

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 5; MESSENGER RNA; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TH2 CELL;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEXAMETHASONE; GATA3 TRANSCRIPTION FACTOR; HELA CELLS; HUMANS; HYDROCORTISONE; IMMUNOPRECIPITATION; INTERLEUKIN-5; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 70349316336     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-121236     Document Type: Article

References (68)

1. Chrousos, G. P. (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351-1362
2. Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M. J., and Young, H. A. (1995) Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 270, 12548-12556
3. Ashwell, J. D., Lu, F. W., and Vacchio, M. S. (2000) Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345
4. Cupps, T. R., and Fauci, A. S. (1982) Corticosteroid-mediated immunoregulation in man. Immunol. Rev. 65, 133-155
5. Kovalovsky, D., Paez Pereda, M., Sauer, J., Perez Castro, C., Nahmod, V. E., Stalla, G. K., Holsboer, F., and Arzt, E. (1998) The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1. Eur. J. Immunol. 28, 2075-2085 (Pubitemid 28321290)
6. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J. J., Chrousos, G. P., and Bornstein, S. R. (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16, 61-71 (Pubitemid 34027951)
7. Laue, L., Kawai, S., Brandon, D. D., Brightwell, D., Barnes, K., Knazek, R. A., Loriaux, D. L., and Chrousos, G. P. (1988) Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J. Steroid Biochem. 29, 591-598 (Pubitemid 18160416)
8. Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., and Balow, J. E. (1993) Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119, 1198-1208
9. Giguere, V., Hollenberg, S. M., Rosenfeld, M. G., and Evans, R. M. (1986) Functional domains of the human glucocorticoid receptor. Cell 46, 645-652 (Pubitemid 16020058)
10. Nissen, R. M., and Yamamoto, K. R. (2000) The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329
11. Jonat, C., Rahmsdorf, H. J., Park, K. K., Cato, A. C., Gebel, S., Ponta, H., and Herrlich, P. (1990) Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204 (Pubitemid 20333778)
12. Yang-Yen, H. F., Chambard, J. C., Sun, Y. L., Smeal, T., Schmidt, T. J., Drouin, J., and Karin, M. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205-1215 (Pubitemid 20333779)
13. Schule, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., and Evans, R. M. (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62, 1217-1226 (Pubitemid 20333780)
14. Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., and Van der Saag, P. T. (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol. Endocrinol. 9, 401-412
15. Biola, A., Andreau, K., David, M., Sturm, M., Haake, M., Bertoglio, J., and Pallardy, M. (2000) The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett. 487, 229-233 (Pubitemid 32063092)
16. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2000) Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J. Neuroimmunol. 109, 16-22 (Pubitemid 30676418)
17. De Bosscher, K., Vanden Berghe, W., and Haegeman, G. (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24, 488-522 (Pubitemid 37059110)
18. Gottlicher, M., Heck, S., and Herrlich, P. (1998) Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76, 480-489 (Pubitemid 28261257)
19. Reichardt, H. M., Tuckermann, J. P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schutz, G. (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20, 7168-7173 (Pubitemid 34062308)
20. Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., and Baldwin, A. S., Jr. (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953
21. Adcock, I. M. (2001) Glucocorticoid-regulated transcription factors. Pulm. Pharmacol. Ther. 14, 211-219
22. Ho, I. C., Vorhees, P., Marin, N., Oakley, B. K., Tsai, S. F., Orkin, S. H., and Leiden, J. M. (1991) Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J. 10, 1187-1192 (Pubitemid 21905580)
23. Pandolfi, P. P., Roth, M. E., Karis, A., Leonard, M. W., Dzierzak, E., Grosveld, F. G., Engel, J. D., and Lindenbaum, M. H. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11, 40-44
24. Hendriks, R. W., Nawijn, M. C., Engel, J. D., van Doorninck, H., Grosveld, F., and Karis, A. (1999) Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29, 1912-1918 (Pubitemid 29265546)
25. Zheng, W., and Flavell, R. A. (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (Pubitemid 27511769)
26. Zhang, D. H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. (1997) Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597-21603 (Pubitemid 27374036)
27. Zhang, D. H., Yang, L., Cohn, L., Parkyn, L., Homer, R., Ray, P., and Ray, A. (1999) Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11, 473-482 (Pubitemid 29504202)
28. Hamid, Q., Azzawi, M., Ying, S., Moqbel, R., Wardlaw, A. J., Corrigan, C. J., Bradley, B., Durham, S. R., Collins, J. V., and Jeffery, P. K. (1991) Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87, 1541-1546
29. Zhang, D. H., Yang, L., and Ray, A. (1998) Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821 (Pubitemid 28468953)
30. Ouyang, W., Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L., Sha, W. C., and Murphy, K. M. (1998) Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755 (Pubitemid 28557602)
31. Ferber, I. A., Lee, H. J., Zonin, F., Heath, V., Mui, A., Arai, N., and O'Garra, A. (1999) GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91, 134-144 (Pubitemid 29203412)
32. Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., and Murphy, K. M. (2000) Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 27-37 (Pubitemid 30069212)
33. Chen, C. H., Zhang, D. H., LaPorte, J. M., and Ray, A. (2000) Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165, 5597-5605
34. Maneechotesuwan, K., Xin, Y., Ito, K., Jazrawi, E., Lee, K. Y., Usmani, O. S., Barnes, P. J., and Adcock, I. M. (2007) Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J. Immunol. 178, 2491-2498 (Pubitemid 46233450)
35. Klein-Hessling, S., Jha, M. K., Santner-Nanan, B., Berberich-Siebelt, F., Baumruker, T., Schimpl, A., and Serfling, E. (2003) Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells. J. Immunol. 170, 2956-2961 (Pubitemid 36302167)
36. Furst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., and Vollmar, A. M. (2007) MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J. 21, 74-80 (Pubitemid 46052546)
37. Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., and Clark, A. R. (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22, 7802-7811 (Pubitemid 35217291)
38. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher, L. H. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669
39. Liberman, A. C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F., and Arzt, E. (2007) The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21, 1177-1188 (Pubitemid 46495707)
40. Raiden, S., Polack, E., Nahmod, V., Labeur, M., Holsboer, F., and Arzt, E. (1995) TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. J. Clin. Immunol. 15, 242-249
41. Siegel, M. D., Zhang, D. H., Ray, P., and Ray, A. (1995) Activation of the interleukin-5 promoter by cAMP in murine EL4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270, 24548-24555
42. Hwang, E. S., Choi, A., and Ho, I. C. (2002) Transcriptional regulation of GATA-3 by an intronic regulatory region and fetal liver zinc finger protein 1. J. Immunol. 169, 248-253 (Pubitemid 34686142)
43. Lee, H. J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S., O'Garra, A., and Arai, N. (2000) GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192, 105-115 (Pubitemid 30470811)
44. Lee, H. J., Masuda, E. S., Arai, N., Arai, K., and Yokota, T. (1995) Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. Involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression. J. Biol. Chem. 270, 17541-17550
45. Kovalovsky, D., Refojo, D., Liberman, A. C., Hochbaum, D., Pereda, M. P., Coso, O. A., Stalla, G. K., Holsboer, F., and Arzt, E. (2002) Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol. Endocrinol. 16, 1638-1651 (Pubitemid 34746009)
46. Lee, H. J., Koyano-Nakagawa, N., Naito, Y., Nishida, J., Arai, N., Arai, K., and Yokota, T. (1993) cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151, 6135-6142 (Pubitemid 23340359)
47. Rupprecht, R., Arriza, J. L., Spengler, D., Reul, J. M., Evans, R. M., Holsboer, F., and Damm, K. (1993) Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol. Endocrinol. 7, 597-603 (Pubitemid 23138168)
48. Tanos, T., Marinissen, M. J., Leskow, F. C., Hochbaum, D., Martinetto, H., Gutkind, J. S., and Coso, O. A. (2005) Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J. Biol. Chem. 280, 18842-18852 (Pubitemid 41379586)
49. Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A. C., Hopfner, U., Grubler, Y., Chervin, A., Goldberg, V., Goya, R., Hentges, S. T., Low, M. J., Holsboer, F., Stalla, G. K., and Arzt, E. (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc. Natl. Acad. Sci. U. S. A. 100, 1034-1039 (Pubitemid 36183950)
50. Costas, M., Trapp, T., Pereda, M. P., Sauer, J., Rupprecht, R., Nahmod, V. E., Reul, J. M., Holsboer, F., and Arzt, E. (1996) Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J. Clin. Invest. 98, 1409-1416 (Pubitemid 26322066)
51. Mori, A., Kaminuma, O., Suko, M., Inoue, S., Ohmura, T., Hoshino, A., Asakura, Y., Miyazawa, K., Yokota, T., Okumura, Y., Ito, K., and Okudaira, H. (1997) Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 89, 2891-2900 (Pubitemid 27172576)
52. Jee, Y. K., Gilmour, J., Kelly, A., Bowen, H., Richards, D., Soh, C., Smith, P., Hawrylowicz, C., Cousins, D., Lee, T., and Lavender, P. (2005) Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J. Biol. Chem. 280, 23243-23250 (Pubitemid 40853236)
53. Quan, A., McCall, M. N., and Sewell, W. A. (2001) Dexamethasone inhibits the binding of nuclear factors to the IL-5 promoter in human CD4 T cells. J. Allergy. Clin. Immunol. 108, 340-348
54. Caelles, C., Gonzalez-Sancho, J. M., and Munoz, A. (1997) Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11, 3351-3364 (Pubitemid 28023959)
55. Betz, M., and Fox, B. S. (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113
56. Pelaia, G., Cuda, G., Vatrella, A., Grembiale, R. D., De Sarro, G., Maselli, R., Costanzo, F. S., Avvedimento, V. E., Rotiroti, D., and Marsico, S. A. (2001) Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem. Pharmacol. 62, 1719-1724 (Pubitemid 34033659)
57. Lasa, M., Brook, M., Saklatvala, J., and Clark, A. R. (2001) Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21, 771-780 (Pubitemid 32104726)
58. Arthur, J. S., and Cohen, P. (2000) MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett. 482, 44-48
59. Beck, I. M., Vanden Berghe, W., Vermeulen, L., Bougarne, N., Vander Cruyssen, B., Haegeman, G., and De Bosscher, K. (2008) Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J. 27, 1682-1693
60. Sakai, D. D., Helms, S., Carlstedt-Duke, J., Gustafsson, J. A., Rottman, F. M., and Yamamoto, K. R. (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2, 1144-1154
61. Novac, N., Baus, D., Dostert, A., and Heinzel, T. (2006) Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J. 20, 1074-1081 (Pubitemid 44943903)
62. Stranick, K. S., Zambas, D. N., Uss, A. S., Egan, R. W., Billah, M. M., and Umland, S. P. (1997) Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. J. Biol. Chem. 272, 16453-16465 (Pubitemid 27276472)
63. Cho, J. Y., Grigura, V., Murphy, T. L., and Murphy, K. (2003) Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-gamma promoter. Int. Immunol. 15, 1149-1160 (Pubitemid 37220489)
64. Hwang, E. S., Hong, J. H., and Glimcher, L. H. (2005) IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J. Exp. Med. 202, 1289-1300
65. Miyaura, H., and Iwata, M. (2002) Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J. Immunol. 168, 1087-1094 (Pubitemid 34094472)
66. Ramirez, F. (1998) Glucocorticoids induce a Th2 response in vitro. Dev. Immunol. 6, 233-243
67. Daynes, R. A., and Araneo, B. A. (1989) Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19, 2319-2325
68. Brinkmann, V., and Kristofic, C. (1995) Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets. J. Immunol. 155, 3322-3328